Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sensus Healthcare, Inc. (SRTS : NSDQ)
 
 • Company Description   
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.

Number of Employees: 54

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.31 Daily Weekly Monthly
20 Day Moving Average: 87,640 shares
Shares Outstanding: 16.44 (millions)
Market Capitalization: $54.42 (millions)
Beta: 1.38
52 Week High: $9.33
52 Week Low: $3.03
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.41% 5.46%
12 Week -41.42% -43.76%
Year To Date -52.17% -57.56%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
851 BROKEN SOUND PARKWAY NW SUITE 215
-
BOCA RATON,FL 33487
USA		 ph: 561-922-5808
fax: 561-948-2071		 tpatel@allianceadvisors.com http://www.sensushealthcare.com
 
 • General Corporate Information   
Officers
Joseph Sardano - Chief Executive Officer and Chairman
Javier Rampolla - Chief Financial Officer
Megan Cornish - Director
William H. McCall - Director
Anthony B. Petrelli - Director

Peer Information
Sensus Healthcare, Inc. (ABMD)
Sensus Healthcare, Inc. (DMDS)
Sensus Healthcare, Inc. (CPWY.)
Sensus Healthcare, Inc. (EQUR)
Sensus Healthcare, Inc. (ECIA)
Sensus Healthcare, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81728J109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/13/25
Share - Related Items
Shares Outstanding: 16.44
Most Recent Split Date: (:1)
Beta: 1.38
Market Capitalization: $54.42 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.05
Price/Cash Flow: 7.66
Price / Sales: 1.45
EPS Growth
vs. Year Ago Period: -160.00%
vs. Previous Quarter: 62.50%
Sales Growth
vs. Year Ago Period: -20.82%
vs. Previous Quarter: -12.33%
ROE
09/30/25 - -
06/30/25 - -1.58
03/31/25 - 3.34
ROA
09/30/25 - -
06/30/25 - -1.41
03/31/25 - 3.00
Current Ratio
09/30/25 - -
06/30/25 - 8.14
03/31/25 - 8.06
Quick Ratio
09/30/25 - -
06/30/25 - 5.79
03/31/25 - 5.74
Operating Margin
09/30/25 - -
06/30/25 - -2.26
03/31/25 - 4.56
Net Margin
09/30/25 - -
06/30/25 - -2.26
03/31/25 - 4.56
Pre-Tax Margin
09/30/25 - -
06/30/25 - -1.31
03/31/25 - 8.76
Book Value
09/30/25 - -
06/30/25 - 3.17
03/31/25 - 3.22
Inventory Turnover
09/30/25 - -
06/30/25 - 1.24
03/31/25 - 1.18
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©